Tech

Psyence Biomedical experiences a dramatic surge in its stock value as its subsidiary, Psyence Australia, receives approval from the Human Research Ethics Committee (HREC) to

Scorpius Holdings Public Offering and Pricing Details Scorpius Holdings, a prominent contract development and manufacturing organization (CDMO), has announced the pricing of its underwritten public

Amylyx Pharmaceuticals experiences a significant drop in its stock value after its drug for amyotrophic lateral sclerosis (ALS) failed to demonstrate benefits for patients in